Wandercraft, a healthtech company in dynamic robotics and exoskeleton technology, has raised USD45 million in a series C round led by the US fund Quadrant Management plus existing investors Bpifrance and new participants MACSF, Malakoff Humanis, AG2R La Mondiale, Mutuelles Impact and Sofiouest.
Other existing investors Xange, Eurazeo, LBO France and Cemag Invest also participated to the round.
Most of this new round of financing will be used by Wandercraft to fulfil the company’s mission of “mobility for all”, through the continued development, then launch, of the new Personal Exoskeleton for outdoor and home use. The funding will also allow Wandercraft to accelerate the deployment of Atalante, its pioneering CE marked rehabilitation exoskeleton, in the USA.
In connection with the financing, Alan Quasha Chairman and CEO of Quadrant Management will join the Wandercraft’s Board of Directors.
